These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Xanthomas: a marker for hyperlipidemias. Lugo-Somolinos A, Sánchez JE. Bol Asoc Med P R; 2003 Jun; 95(4):12-6. PubMed ID: 15032023 [Abstract] [Full Text] [Related]
6. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia. Gianturco SH, Gotto AM, Jackson RL, Patsch JR, Sybers HD, Taunton OD, Yeshurun DL, Smith LC. J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612 [Abstract] [Full Text] [Related]
8. Contribution of xanthoma tissue-derived LDL density substances in the transformation of macrophages to foam cells. Ikeda M, Nakajima K, Nakajima H, Matsumoto M, Seike M, Kodama H. J Dermatol Sci; 2006 Dec; 44(3):161-8. PubMed ID: 17092695 [Abstract] [Full Text] [Related]
10. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ, Guérin M, Bruckert E. Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [Abstract] [Full Text] [Related]
11. [Ultrastructural study in four cases of cutaneous xanthomas in children (author's transl)]. Schnitzler L, Verret JL. Ann Dermatol Venereol; 1979 Mar; 106(3):243-7. PubMed ID: 225978 [Abstract] [Full Text] [Related]
20. Xanthoma tissue-extracted LDL density substances are the main inducer of myelin-like bodies and ceroid granules in foam cells. Nakajima K, Ikeda M, Yagyu K, Nakajima H, Matsumoto M, Seike M, Kodama H. Med Mol Morphol; 2007 Mar 22; 40(1):40-5. PubMed ID: 17384989 [Abstract] [Full Text] [Related] Page: [Next] [New Search]